文献速递胸部肿瘤放疗放疗物理与技术

随机试验中比较调强光子治疗与被动散射质子治疗局部晚期非小细胞肺癌的放射性肺炎相关空间剂量模式

Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-02-26

该研究分析178例接受调强放疗或被动散射质子治疗并同步化疗的局部晚期非小细胞肺癌患者,处方剂量66或74 Gy常规分割,40例(22%)出现有症状的放射性肺炎。基于体素分析发现,有无放射性肺炎患者在下肺和心脏区域存在显著剂量差异,且质子治疗显著保护的区域与剂量显著相关于放射性肺炎发生的体素簇不重叠。

要点

  • 178例局部晚期非小细胞肺癌患者中40例(22%)发生有症状放射性肺炎。
  • 体素分析显示有无放射性肺炎患者在下肺和心脏区域存在显著剂量差异。
  • 被动散射质子治疗显著保护的区域与放射性肺炎相关剂量簇不重叠。

核心结论

  • 分析试验数据为先前关于心脏和下肺在放射性肺炎发生中作用的假设提供了验证机会。
  • 放射性肺炎与胸部区域放射敏感性的关系应纳入临床实践和未来试验设计考虑。

研究设计与样本

  • 分析178例前瞻性接受被动散射质子治疗或调强放疗的非小细胞肺癌患者,处方剂量66或74 Gy常规每日分割并同步化疗。
  • 采用基于体素的局部剂量差异分析,使用非参数置换检验校正多重比较。
  • 从获得的三维显著性图中,提取组间剂量差异达到0.05统计学显著性水平的体素簇。

主要发现

  • 40例患者(22%)出现临床有症状的放射性肺炎。
  • 体素分析显示有无放射性肺炎患者在下肺和心脏区域存在显著剂量差异。
  • 被动散射质子治疗显著保护的区域与剂量显著相关于放射性肺炎发生的体素簇不重叠。

临床怎么用

  • 作者认为放射性肺炎与胸部区域放射敏感性的关系应纳入临床实践和未来试验设计考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation pneumonitis (RP) is commonly associated with thoracic radiation therapy, and its incidence is related to dose and volume of the normal lung in the path of radiation. Our aim was to investigate dose patterns associated with RP in patients enrolled in a randomized trial of intensity modulated radiation therapy (IMRT) versus passive scattering proton therapy (PSPT) for locally advanced non-small cell lung cancer. METHODS: We analyzed 178 patients prospectively treated with PSPT or IMRT for non-small cell lung cancer to a prescribed dose of 66 or 74 Gy in conventional daily fractionation with concurrent chemotherapy. Forty patients (22%) developed clinically symptomatic RP. Voxel-based analysis of local dose differences was done with a nonparametric permutation test accounting for multiple comparisons. From the obtained 3-dimensional significance maps, we derived clusters of voxels that exhibited dose differences between groups at a statistical significance level of 0.05. RESULTS: The voxel-based analysis highlighted that (1) significant dose differences between patients with and without RP were found in the lower part of the lungs and in the heart and (2) the anatomic regions significantly spared by PSPT and the clusters in which doses were significantly correlated with RP development were disjoint. CONCLUSIONS: The analyzed trial data provide an unprecedented opportunity to substantiate previous hypotheses regarding the role of the heart and the lower lungs in the development of RP. Knowledge of this relationship between RP and thoracic regional radiosensitivity should be considered in clinical practice and in the design of future trials.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Palma G, Monti S, Xu T, et al. Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019. PMID: 30822531. doi:10.1016/j.ijrobp.2019.02.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。